Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Ocugen Stock Surged Today

TheMotleyFool

0 0

Why Ocugen Stock Surged TodayPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png

Shares of Ocugen (NASDAQ: OCGN) climbed on Wednesday after the biopharmaceutical company's partner, Bharat Biotech, released promising results from a phase 3 trial of its COVID-19 vaccine candidate, Covaxin.

As of 3 p.m. EDT, Ocugen's stock price was up more than 12% after rising as much as 22.5% earlier in the day.

A second interim analysis of a phase 3 study with 25,800 participants showed Covaxin to have efficacy against mild, moderate, and severe COVID-19 of 78%. Against severe COVID-19 alone, that figure came in at 100%.

Source Fool.com

Like: 0

OCGN

Share